Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients

作者
Cristina López,Nathalie Depreux,Isabel Bielsa,A Roger,Bibiana Quirant‐Sánchez,María Basagaña,Yanina Jurgens,Clara Padró,Sira Miquel,Eva María Martínez-Cáceres,Aina Teniente‐Serra
出处
期刊:Frontiers in Immunology [Frontiers Media]
卷期号:15: 1413233-1413233 被引量:4
标识
DOI:10.3389/fimmu.2024.1413233
摘要

Background: Chronic spontaneous urticaria (CSU) is a highly prevalent and difficult to manage cutaneous disease characterized by the presence of recurrent urticaria, angioedema, or both, for a period of 6 weeks or longer. One of the biological treatments used for patients with CSU with an autoimmune background and bad control of the disease is omalizumab, an anti-IgE monoclonal antibody. The understanding of the mechanism of action of this biological drug in CSU along with the identification of potential biomarkers of clinical response can be helpful in the personalized management of the disease. Objective: The purpose of this study was to analyze the effect of omalizumab on peripheral blood lymphocyte subpopulations in patients with CSU in order to identify potential biomarkers of treatment response. Methods: We analyzed 71 patients with CSU [33 under omalizumab and 38 under non-immunomodulatory drugs (treated with antihistamines; NID)] and 50 healthy controls. An exhaustive immunophenotyping of whole blood T-cell subpopulations, including naïve, central memory, effector memory, effector cells, Th1, Th2, and Th17 was performed by multiparametric flow cytometry. Moreover, in CSU patients, we analyzed markers of inflammation (ESR, DD, CRP), atopy (prick test, IgE quantification), and autoimmunity (anti-thyroid antibodies and indirect basophil activation test).To evaluate the clinical activity, the Urticaria Activity Score 7 (UAS 7) test was used. Results: In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. Moreover, patients under treatment with omalizumab had higher percentages of Th1 and Th2 cells than patients under treatment with NID. Conclusion: The immune monitoring of T-cell subpopulations in patients with CSU starting omalizumab, may be a useful strategy to analyze treatment response in the clinical practice.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
李健的小迷弟的应助被太宰治采纳,获得10
1秒前
jinyega完成签到,获得积分10
1秒前
妙aaa完成签到,获得积分10
1秒前
初(*^▽^*)心的应助被小乐采纳,获得10
1秒前
我是发布了新的文献求助10
1秒前
2秒前
斐然诗发布了新的文献求助60
2秒前
可爱的函函的应助被研友_n01QxZ采纳,获得10
3秒前
Hello的应助被未知采纳,获得10
3秒前
YUYUYYU发布了新的文献求助20
3秒前
信仰完成签到,获得积分10
4秒前
Hyperion完成签到,获得积分10
4秒前
zhonglv7完成签到,获得积分0
4秒前
4秒前
陈鑫完成签到,获得积分10
4秒前
CaliU完成签到,获得积分10
4秒前
4秒前
clement完成签到,获得积分10
5秒前
5秒前
Daniel完成签到,获得积分10
5秒前
5秒前
鸡鱼蚝完成签到,获得积分10
5秒前
6秒前
6秒前
jiang发布了新的文献求助10
6秒前
晚枫完成签到,获得积分10
6秒前
李治海完成签到,获得积分10
7秒前
幸福的安双完成签到 ,获得积分10
7秒前
勤奋尔丝完成签到 ,获得积分10
7秒前
奔跑的应助被沐风采纳,获得10
7秒前
闹闹发布了新的文献求助10
8秒前
8秒前
科目三的应助被程大大大教授采纳,获得10
8秒前
莫断痕的应助被xxy采纳,获得10
8秒前
哭泣觅儿发布了新的文献求助10
8秒前
可靠若云发布了新的文献求助10
9秒前
瓦洛佳完成签到,获得积分10
9秒前
lll发布了新的文献求助10
9秒前
斯文败类的应助被愉快的宛秋采纳,获得10
9秒前
CodeCraft的应助被Clarence采纳,获得10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8174136
求助须知:如何正确求助?哪些是违规求助? 9566193
关于积分的说明 21785238
捐赠科研通 7768317
什么是DOI,文献DOI怎么找? 3431698
关于科研通互助平台的介绍 2555912
邀请新用户注册赠送积分活动 2476956